Synergy Pharmaceuticals LLC engages on the development and commercialization of novel gastrointestinal therapies. Its commercial product, plecanatide, is marketed under the trademark name TRULANCE, which seeks to treat adults with chronic idiopathic constipation and irritable bowel syndrome with constipation. The company was founded by Kunwar Shailubhai and is headquartered in New York, NY.
Sector:
Health Technology
Industry:
Pharmaceuticals Other
Employees:
Frequently Asked Questions
What is Market Cap of Synergy Pharmaceuticals Incorporated?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Synergy Pharmaceuticals Incorporated market cap is $1.59M.
What is the 52-week high for Synergy Pharmaceuticals Incorporated?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Synergy Pharmaceuticals Incorporated 52 week high is $2.10 as of October 26, 2025.
What is the 52-week low for Synergy Pharmaceuticals Incorporated?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Synergy Pharmaceuticals Incorporated 52 week low is $0.005 as of October 26, 2025.
What is Synergy Pharmaceuticals Incorporated stock price today?
Synergy Pharmaceuticals Incorporated stock price today is $0.0064.
What was Synergy Pharmaceuticals Incorporated stock price yesterday?
Synergy Pharmaceuticals Incorporated stock price yesterday was $0.0067.
What is the PE ratio of Synergy Pharmaceuticals Incorporated?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Synergy Pharmaceuticals Incorporated’s P/E ratio is None.
What is the Price-to-Book ratio of Synergy Pharmaceuticals Incorporated?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Synergy Pharmaceuticals Incorporated P/B ratio is -0.0165.
What is Synergy Pharmaceuticals Incorporated's EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Synergy Pharmaceuticals Incorporated's EBITDA is N/A.
What is the 50-day moving average of Synergy Pharmaceuticals Incorporated?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Synergy Pharmaceuticals Incorporated 50-day moving average is $0.0438.
How many employess does Synergy Pharmaceuticals Incorporated has?
Synergy Pharmaceuticals Incorporated has N/A employees.
